Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Amphastar’s argument with respect to bidding on GPO contacts does not hold water, IMO. Thus, the pending decision of consequence in this case is whether the Judge will grant MNTA’s Motion for limited expedited discovery. If the Judge does allow limited expedited discovery, I think it’s close to 100% that he will also keep the TRO in effect (or issue a new TRO to supersede the old one).